SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-039750
Filing Date
2021-10-08
Accepted
2021-10-08 18:30:49
Documents
1
Period of Report
2021-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 18323
  Complete submission text file 0000899243-21-039750.txt   19664
Mailing Address 712 COLLEGE AVENUE MENLO PARK CA 94025
Business Address
Kong Garheng (Reporting) CIK: 0001435183 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40880 | Film No.: 211316303

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations